— Know what they know.
Not Investment Advice

IMRSQ OTC

IMRIS Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 54 · $626 mcap · 40M float · 0.082% daily turnover

Income Trends

Revenue
$29M -37.3% ▼
5Y CAGR: -7.4%
Gross Profit
$10M -36.6% ▼
5Y CAGR: -12.0%
Operating Income
-$23M +41.1% ▲
Net Income
-$30M +27.7% ▲
EPS (Diluted)
$-0.58 +30.1% ▲
EBITDA
-$23M +38.8% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2010FY2011FY2012FY2013FY2014
Revenue$70M$52M$52M$46M$29M
YoY Growth+65.7%-26.3%+1.1%-12.1%-37.3%
Cost of Revenue$41M$34M$35M$30M$19M
Gross Profit$31M$18M$18M$16M$10M
Gross Margin43.6%34.1%34.0%34.0%34.4%
R&D Expenses$6M$9M$15M$18M$7M
SG&A Expenses$23M$26M$18M$22M$14M
Operating Expenses$31M$38M$45M$55M$33M
Operating Income-$981K-$21M-$28M-$39M-$23M
Operating Margin-1.4%-39.7%-52.5%-85.4%-80.1%
Interest Expense$0$0$40K$1M$5M
Income Before Tax-$2M-$21M-$28M-$42M-$30M
Tax Expense$0-$366K$86K$144K$242K
Net Income-$2M-$21M-$28M-$42M-$30M
Net Margin-2.5%-40.4%-53.0%-91.2%-105.2%
EPS (Diluted)$-0.04$-0.47$-0.61$-0.83$-0.58
EBITDA$3M-$17M-$24M-$37M-$23M
Shares Outstanding34M45M46M51M52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms